Imunon, Inc. 0HUZ.L Stock
Imunon, Inc. Price Chart
Imunon, Inc. 0HUZ.L Financial and Trading Overview
| Imunon, Inc. stock price | 1.35 USD |
| Previous Close | 1.47 USD |
| Open | 0 USD |
| Bid | 0 USD x N/A |
| Ask | 0 USD x N/A |
| Day's Range | 0 - 0 USD |
| 52 Week Range | 0 - 2.63 USD |
| Volume | 7.37K USD |
| Avg. Volume | 2.64K USD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 2.068661 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.968 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0HUZ.L Valuation Measures
| Enterprise Value | -10272155 USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.46486858 |
| Enterprise Value/Revenue | -27.392 |
| Enterprise Value/EBITDA | 0.428 |
Trading Information
Imunon, Inc. Stock Price History
| Beta (5Y Monthly) | 2.068661 |
| 52-Week Change | -27.11% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.63 USD |
| 52 Week Low | 0 USD |
| 50-Day Moving Average | 1.45 USD |
| 200-Day Moving Average | 1.6 USD |
0HUZ.L Share Statistics
| Avg. Volume (3 month) | 2.64K USD |
| Avg. Daily Volume (10-Days) | 2.05K USD |
| Shares Outstanding | N/A |
| Float | 9.06M |
| Short Ratio | N/A |
| % Held by Insiders | 1.13% |
| % Held by Institutions | 4.69% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 0.066667:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -6603.74% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -29.080% |
| Return on Equity (ttm) | -85.075% |
Income Statement
| Revenue (ttm) | 375K USD |
| Revenue Per Share (ttm) | 0.05 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 500K USD |
| EBITDA | -24013720 USD |
| Net Income Avi to Common (ttm) | -31015268 USD |
| Diluted EPS (ttm) | -3.968 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 31.18M USD |
| Total Cash Per Share (mrq) | 3.43 USD |
| Total Debt (mrq) | 7.57M USD |
| Total Debt/Equity (mrq) | 28.42 USD |
| Current Ratio (mrq) | 3.487 |
| Book Value Per Share (mrq) | 2.929 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -19240534 USD |
| Levered Free Cash Flow (ttm) | -13956028 USD |
Profile of Imunon, Inc.
| Country | United Kingdom |
| State | NJ |
| City | Lawrenceville |
| Address | 997 Lenox Drive |
| ZIP | 08648 |
| Phone | 609 896 9100 |
| Website | https://www.imunon.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 31 |
Imunon, Inc., a clinical stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The Company's lead clinical programs comprise IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development; and ThermoDox for the treatment of hepatocellular carcinoma. It also has two platform technologies, such as TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies; and PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. Imunon, Inc. was founded in 1982 and is based in Lawrenceville, New Jersey.
Q&A For Imunon, Inc. Stock
What is a current 0HUZ.L stock price?
Imunon, Inc. 0HUZ.L stock price today per share is 1.35 USD.
How to purchase Imunon, Inc. stock?
You can buy 0HUZ.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Imunon, Inc.?
The stock symbol or ticker of Imunon, Inc. is 0HUZ.L.
How many shares does Imunon, Inc. have in circulation?
The max supply of Imunon, Inc. shares is 0.
What is Imunon, Inc. Price to Earnings Ratio (PE Ratio)?
Imunon, Inc. PE Ratio is now.
What was Imunon, Inc. earnings per share over the trailing 12 months (TTM)?
Imunon, Inc. EPS is -3.968 USD over the trailing 12 months.